動物用医薬品市場：製品タイプ、動物タイプ、投与方法、適応症、流通チャネル、エンドユーザー別-2025年～2030年世界予測

動物用医薬品市場の2023年の市場規模は374億6,000万米ドルで、2024年には405億3,000万米ドルに達すると予測され、CAGR 8.35%で成長し、2030年には657億1,000万米ドルに達すると予測されています。

動物用医薬品市場には、動物の健康と福祉を確保することを目的としたワクチン、抗感染症薬、寄生虫駆除薬など、幅広い製品が含まれます。これらの医薬品の必要性は、家畜生産の増加、ペット飼育の重要性の高まり、効果的な疾病対策への需要によって生じる。用途はコンパニオンアニマル（猫、犬）から家畜（牛、豚）まで幅広く、動物病院やオンライン薬局などのエンドユーザー部門にサービスを提供しています。この市場の主な成長要因は、獣医学研究の進歩、ペットヘルスケア支出の増加、動物福祉に対する意識の高まりなどです。人獣共通感染症の増加も、効果的な動物用医薬品の需要を煽っています。潜在的なビジネスチャンスは、ゲノム学と診断学の進歩による個別化ペット医療の拡大にあります。eコマースの台頭も有望な手段であり、利便性と幅広い市場リーチを提供します。しかし、新興国市場の成長は、厳しい規制の枠組み、薬剤開発の高コスト、偽造品に関する問題など、市場浸透の妨げとなる課題に直面しています。さらに、熟練した獣医専門家の不足が、特定の地域での成長を制限する可能性もあります。技術革新は、特に新興の健康脅威に対応する生物製剤と先進ワクチンの開発に集中する可能性があります。遠隔獣医療サービスを提供するデジタル・プラットフォームも、デジタル・ヘルス・ソリューションに対する消費者の嗜好に合致して、大幅な成長を遂げる可能性があります。市場は本質的にダイナミックであり、急速な科学的進歩と進化する消費者の需要によって特徴付けられ、利害関係者が機敏に適応し続けることの重要性を浮き彫りにしています。データ主導の洞察のためにテクノロジー企業と提携したり、新興国地域の未開拓市場を開拓したりすることで、競合優位性が得られる可能性があります。企業はまた、リスクを軽減し、規制状況を効果的にナビゲートするために、強固なサプライチェーン・ネットワークの構築に投資し、着実な成長と市場での強靭なポジショニングを目指すべきです。

市場力学：急速に進化する動物用医薬品市場の主要市場インサイトを公開

動物用医薬品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 家畜およびコンパニオンアニマルの疾病発生率の増加、治療と投薬のニーズの高まり
  • 動物用ヘルスケアに関する研究開発活動の増加
• 市場抑制要因
  • 動物用医薬品とワクチンに関連するリコールのリスク
• 市場機会
  • 新しく先進的な動物用医薬品の開発
  • 動物用ワクチン施設拡張のための企業による投資の増加
• 市場の課題
  • 動物用ワクチンの副作用に関する懸念

ポーターの5つの力：動物用医薬品市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用医薬品市場における外部からの影響の把握

外部マクロ環境要因は、動物用医薬品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用医薬品市場における競合情勢の把握

動物用医薬品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用医薬品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用医薬品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用医薬品市場における成功への道筋を描く

動物用医薬品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 家畜やペットの病気の発生率が増加し、治療や医薬品の必要性が高まっている
    • 獣医ヘルスケアの研究開発活動の増加
  • 抑制要因
    • 獣医用医薬品およびワクチンに関連するリコールのリスク
  • 機会
    • 新しい高度な動物用医薬品の開発
    • 獣医用ワクチン施設の拡張に向けた企業による投資増加
  • 課題
    • 獣医用ワクチンの副作用に関する懸念
• 市場セグメンテーション分析
  • 製品：動物の健康と生産性を向上させるための医療用飼料の需要の高まり
  • 動物タイプ：病気の抑制と生産性の向上により、家畜における動物用医薬品の必要性の高まり
  • 投与方法：投与量の正確性を確保するためにカプセルの利用を増やす
  • 適応症：代謝障害の治療を進歩させる薬剤のイントロダクション新たな焦点
  • 流通チャネル：利便性と幅広い製品ラインナップにより、オンライン薬局に対する消費者の嗜好が高まっている
  • エンドユーザー：ペットオーナーによる動物用医薬品の用途拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用医薬品市場：製品別

• 薬物
  • 鎮痛剤
  • 抗感染薬
    • 抗生物質
    • 抗真菌薬
  • 抗炎症薬
    • 非ステロイド
    • ステロイド
  • 寄生虫駆除剤
    • 外部寄生虫駆除剤
    • 内部寄生虫駆除剤
• 薬用飼料
  • 抗生物質入り飼料
  • 駆虫薬配合飼料
  • 成長促進剤
  • 栄養薬用飼料
  • プロバイオティクスとプレバイオティクスの薬用飼料
• ワクチン
  • 不活化ワクチン
  • 生ワクチン

第7章 動物用医薬品市場：動物タイプ別

• コンパニオンアニマル
  • 猫
  • 犬
  • 馬
• 家畜
  • 牛
  • 家禽
  • 羊とヤギ
  • 豚

第8章 動物用医薬品市場：投与方法別

• 注射可能
  • 筋肉内
  • 皮下
• 経口
  • カプセル
  • 液体懸濁液およびシロップ
  • タブレット
• 局所
  • クリーム
  • ローション
  • 軟膏

第9章 動物用医薬品市場：適応症別

• 慢性および急性疼痛管理
• 免疫学的状態
• 感染症
• 代謝障害
• 神経疾患
• 整形外科疾患
• 寄生虫感染症
• 生殖に関する健康

第10章 動物用医薬品市場：流通チャネル別

• オンライン薬局
• 小売薬局
• 獣医クリニック

第11章 動物用医薬品市場：エンドユーザー別

• 動物農場
• ペットの飼い主
• 動物病院

第12章 南北アメリカの動物用医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋の動物用医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの動物用医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • デクラ・ファーマシューティカルズ、獣医治療ポートフォリオ強化のためインベックスを買収
  • TechInventionとボツワナ研究所が提携し、獣医用ワクチンの生産に革命を起こす
  • メルクアニマルヘルスが革新的なRNA粒子犬インフルエンザワクチンを発表
  • ヒューベファーマ、7,200万ユーロを投じて獣医用ワクチン工場を拡張し、世界の供給とイノベーションを促進
  • ビルバック、ササエ買収で日本市場での地位を強化
  • FDAの承認により心臓や呼吸器疾患の獣医治療が強化される
  • EVMLが世界の獣医学医薬品のアクセス性とAMR軽減に与える影響
  • ゼンダルとCSICが犬のリーシュマニア症と闘う革新的なネオリーシュワクチンを発表
  • メルクアニマルヘルス、エランコの水産事業を買収し、水産養殖事業を強化
  • 華騰製薬はフルララネルとサロラネルの発売で事業を拡大し、動物用医薬品に革命を起こした
  • ENTOD Pharmaceuticalsが「FUR by ENTOD」部門で獣医市場へ進出
  • インド免疫学社（IIL）は家畜疾病撲滅を促進するためハイデラバードのワクチン工場に700カロールインドルピーを投資
  • ビルバック、インドにおける鳥類ワクチン市場での存在感を高めるためグロビオンの株式を取得
  • ワクチンの革新とパンデミックへの備えを強化するために、パーブライト研究所とUSaskのVIDOが戦略的に協力
• 戦略分析と提言
  • デクラ・ファーマシューティカルズPLC
  • ゾエティス株式会社
  • チェヴァサンテアニマーレ
  • ベーリンガーインゲルハイム

企業一覧

• Aurora Pharmaceutical, Inc.
• Biogenesis Bago S.A.
• Biovac Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Chanelle Pharma
• China Animal Husbandry Industry Co., Ltd.
• Dechra Pharmaceuticals PLC
• ECO Animal Health Group PLC
• Elanco Animal Health Incorporated
• Heska Corporation
• Hester Biosciences Limited
• Indian Immunologicals Ltd.
• Intas Pharmaceuticals Ltd.
• Laboratorio Drag Pharma Chile Invetec S.A.
• Merck & Co., Inc.
• Neogen Corporation
• Norbrook Group
• Phibro Animal Health Corporation
• Teknofarma S.r.l.
• Vetoquinol Group
• Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
• Virbac S.A.
• Zendal Group
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY PHARMACEUTICALS MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. VETERINARY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. VETERINARY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY PHARMACEUTICALS MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NON-STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIPARASITIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROWTH PROMOTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NUTRITIONAL MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PROBIOTIC & PREBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIQUID SUSPENSION & SYRUP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CHRONIC & ACUTE PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 65. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 66. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 67. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 68. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 69. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 70. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 72. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 73. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 74. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 76. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 77. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 78. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 79. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 80. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 81. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 82. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 83. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 84. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 85. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 86. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 87. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 88. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 90. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 91. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 92. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 93. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 96. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 97. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 98. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 99. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 100. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 101. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 102. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 103. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 105. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 106. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 108. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 109. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 110. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 111. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 114. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 115. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 116. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 117. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 118. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 119. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 120. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 121. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 122. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 123. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 124. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 125. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 126. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 127. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 128. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 131. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 132. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 133. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 134. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 135. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 136. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 137. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 138. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 139. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 140. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 141. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 142. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 143. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 144. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 145. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 148. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 149. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 150. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 151. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 152. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 153. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 154. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 155. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 156. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 157. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 159. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 160. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 161. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 162. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 165. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 166. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 167. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 168. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 169. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 170. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 171. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 172. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 173. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 174. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 175. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 176. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 177. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 178. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 179. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 180. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 182. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 183. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 184. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 185. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 186. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 187. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 188. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 189. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 190. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 191. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 192. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 193. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 194. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 195. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 196. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 197. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 198. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 200. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 201. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 202. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 203. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 204. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 205. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 206. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 207. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 208. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 209. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 210. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 211. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 212. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 213. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 214. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 215. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 216. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 218. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 219. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 220. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 221. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 222. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 223. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 224. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 225. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 226. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 227. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 228. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 229. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 230. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 231. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 232. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 233. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 235. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 236. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 237. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 238. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 239. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 240. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 241. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 242. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 243. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 244. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 245. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 246. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 247. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 248. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 249. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 250. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 251. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 252. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 253. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 254. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 255. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 256. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 257. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 258. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 259. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 260. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 261. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 262. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 263. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 264. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 265. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 266. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 267. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 268. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 269. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 270. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 271. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 272. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 273. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 274. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 275. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 276. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 277. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 278. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 279. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 280. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 281. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 282. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 283. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 284. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 285. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 286. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 287. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 288. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 289. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 290. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 291. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 292. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 293. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 294. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 295. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 296. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 297. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 298. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 299. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 300. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 301. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 302. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 303. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 304. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
• TABLE 305. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
• TABLE 306. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
• TABLE 307. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
• TABLE 308. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
• TABLE 309. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 310. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 311. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
• TABLE 312. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 313. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
• TABLE 314. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
• TABLE 315. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
• TABLE 316. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 317. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 318. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 319. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 320. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 321. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANT

The Veterinary Pharmaceuticals Market was valued at USD 37.46 billion in 2023, expected to reach USD 40.53 billion in 2024, and is projected to grow at a CAGR of 8.35%, to USD 65.71 billion by 2030.

The scope of the veterinary pharmaceuticals market encompasses a wide array of products including vaccines, anti-infectives, and parasiticides aimed at ensuring animal health and welfare. Necessity for these pharmaceuticals arises due to increasing livestock production, the rising importance of pet ownership, and the demand for efficacious disease control measures. Applications range from companion animals (cats, dogs) to livestock (cattle, swine), serving end-user sectors like veterinary hospitals and online pharmacies. Key growth factors in this market include advancements in veterinary research, rising pet healthcare expenditure, and increased awareness towards animal welfare. The increasing incidence of zoonotic diseases is also fuelling demand for effective veterinary medications. Potential opportunities lie in the expansion of personalized pet medicine, driven by advancements in genomics and diagnostics. The rise of e-commerce in veterinary pharmaceuticals is another promising avenue, offering convenience and wider market reach. However, market growth faces challenges, such as strict regulatory frameworks, high costs of drug development, and issues related to counterfeit products, which can hinder market penetration. Moreover, the shortage of skilled veterinary professionals may limit growth in certain regions. Innovation could focus on the development of biologics and advanced vaccines, especially for emerging health threats. Digital platforms providing tele-veterinary services could also see substantial growth, aligning with consumer preferences for digital health solutions. The market is inherently dynamic, marked by rapid scientific advancements and evolving consumer demands, highlighting the importance for stakeholders to stay agile and adaptive. Partnering with technology firms for data-driven insights or exploring underpenetrated markets in developing regions could provide competitive advantages. Companies should also invest in building a robust supply chain network to mitigate risks and navigate the regulatory landscape effectively, aiming for steady growth and resilient market positioning.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Pharmaceuticals Market

The Veterinary Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of diseases in livestock and companion animals, rising need for treatment and medications
  • Increase in R&D activities for veterinary healthcare
• Market Restraints
  • Risk of recalls associated with veterinary drugs and vaccines
• Market Opportunities
  • Development of new and advanced veterinary pharmaceuticals
  • Increasing investment by companies for the expansion of veterinary vaccine facilities
• Market Challenges
  • Concerns associated with the adverse effects of veterinary vaccine

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Pharmaceuticals Market

A detailed market share analysis in the Veterinary Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Pharmaceuticals Market

A strategic analysis of the Veterinary Pharmaceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Aurora Pharmaceutical, Inc., Biogenesis Bago S.A., Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma, China Animal Husbandry Industry Co., Ltd., Dechra Pharmaceuticals PLC, ECO Animal Health Group PLC, Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, Indian Immunologicals Ltd., Intas Pharmaceuticals Ltd., Laboratorio Drag Pharma Chile Invetec S.A., Merck & Co., Inc., Neogen Corporation, Norbrook Group, Phibro Animal Health Corporation, Teknofarma S.r.l., Vetoquinol Group, Vetpharma Animal Health S.L. by Insud Pharma S.L.U., Virbac S.A., Zendal Group, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Products, market is studied across Drugs, Medicinal Feed, and Vaccines. The Drugs is further studied across Analgesics, Anti-Infectives, Anti-Inflammatories, and Parasiticides. The Anti-Infectives is further studied across Antibiotics and Antifungals. The Anti-Inflammatories is further studied across Non-Steroidal and Steroidal. The Parasiticides is further studied across Ectoparasiticides and Endoparasiticides. The Medicinal Feed is further studied across Antibiotic Medicated Feed, Antiparasitic Medicated Feed, Growth Promoters, Nutritional Medicated Feed, and Probiotic & Prebiotic Medicated Feed. The Vaccines is further studied across Inactivated Vaccines and Live Vaccines.
• Based on Animal Type, market is studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Livestock Animals is further studied across Cattle, Poultry, Sheep & Goats, and Swine.
• Based on Mode of Administration, market is studied across Injectable, Oral, and Topical. The Injectable is further studied across Intramuscular and Subcutaneous. The Oral is further studied across Capsules, Liquid Suspension & Syrup, and Tablets. The Topical is further studied across Creams, Lotions, and Ointments.
• Based on Indications, market is studied across Chronic & Acute Pain Management, Immunological Conditions, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Orthopedic Disorders, Parasitic Infections, and Reproductive Health.
• Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, and Veterinary Clinics.
• Based on End User, market is studied across Animal Farms, Pet Owners, and Veterinary Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New Jersey, New York, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of diseases in livestock and companion animals, rising need for treatment and medications
    • 5.1.1.2. Increase in R&D activities for veterinary healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. Risk of recalls associated with veterinary drugs and vaccines
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of new and advanced veterinary pharmaceuticals
    • 5.1.3.2. Increasing investment by companies for the expansion of veterinary vaccine facilities
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with the adverse effects of veterinary vaccine
• 5.2. Market Segmentation Analysis
  • 5.2.1. Products: The growing demand for medicinal feed to improve animal health and productivity
  • 5.2.2. Animal Type: Growing need for veterinary pharmaceuticals in livestock animals owing to disease control and productivity enhancement
  • 5.2.3. Mode of Administration: Increasing utilization of capsules for ensuring dosage accuracy
  • 5.2.4. Indications: Emerging focus on the introduction of drugs advancing treatments for metabolic disorders
  • 5.2.5. Distribution Channel: Growing consumer preference for online pharmacies owing to their convenience and wide range of products
  • 5.2.6. End User: Expanding applications of veterinary pharmaceuticals by pet owners
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Pharmaceuticals Market, by Products

• 6.1. Introduction
• 6.2. Drugs
  • 6.2.1. Analgesics
  • 6.2.2. Anti-Infectives
    • 6.2.2.1. Antibiotics
    • 6.2.2.2. Antifungals
  • 6.2.3. Anti-Inflammatories
    • 6.2.3.1. Non-Steroidal
    • 6.2.3.2. Steroidal
  • 6.2.4. Parasiticides
    • 6.2.4.1. Ectoparasiticides
    • 6.2.4.2. Endoparasiticides
• 6.3. Medicinal Feed
  • 6.3.1. Antibiotic Medicated Feed
  • 6.3.2. Antiparasitic Medicated Feed
  • 6.3.3. Growth Promoters
  • 6.3.4. Nutritional Medicated Feed
  • 6.3.5. Probiotic & Prebiotic Medicated Feed
• 6.4. Vaccines
  • 6.4.1. Inactivated Vaccines
  • 6.4.2. Live Vaccines

7. Veterinary Pharmaceuticals Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animals
  • 7.2.1. Cats
  • 7.2.2. Dogs
  • 7.2.3. Horses
• 7.3. Livestock Animals
  • 7.3.1. Cattle
  • 7.3.2. Poultry
  • 7.3.3. Sheep & Goats
  • 7.3.4. Swine

8. Veterinary Pharmaceuticals Market, by Mode of Administration

• 8.1. Introduction
• 8.2. Injectable
  • 8.2.1. Intramuscular
  • 8.2.2. Subcutaneous
• 8.3. Oral
  • 8.3.1. Capsules
  • 8.3.2. Liquid Suspension & Syrup
  • 8.3.3. Tablets
• 8.4. Topical
  • 8.4.1. Creams
  • 8.4.2. Lotions
  • 8.4.3. Ointments

9. Veterinary Pharmaceuticals Market, by Indications

• 9.1. Introduction
• 9.2. Chronic & Acute Pain Management
• 9.3. Immunological Conditions
• 9.4. Infectious Diseases
• 9.5. Metabolic Disorders
• 9.6. Neurological Disorders
• 9.7. Orthopedic Disorders
• 9.8. Parasitic Infections
• 9.9. Reproductive Health

10. Veterinary Pharmaceuticals Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Online Pharmacies
• 10.3. Retail Pharmacies
• 10.4. Veterinary Clinics

11. Veterinary Pharmaceuticals Market, by End User

• 11.1. Introduction
• 11.2. Animal Farms
• 11.3. Pet Owners
• 11.4. Veterinary Hospitals

12. Americas Veterinary Pharmaceuticals Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Veterinary Pharmaceuticals Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Veterinary Pharmaceuticals Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Dechra Pharmaceuticals to acquire Invetx to enhance veterinary therapeutics portfolio
  • 15.3.2. TechInvention and Botswana Institute partner to revolutionize veterinary vaccine production
  • 15.3.3. Merck Animal Health introduces innovative RNA-particle Canine Flu vaccine
  • 15.3.4. Huvepharma Expands with EUR 72 million veterinary vaccine plant to boost global supply and innovation
  • 15.3.5. Virbac strengthens position in Japanese market with Sasaeah acquisition
  • 15.3.6. FDA approvals enhance veterinary treatments for heart and respiratory conditions
  • 15.3.7. Impact of EVML on global veterinary medicine accessibility and AMR mitigation
  • 15.3.8. Zendal and CSIC unveil innovative Neoleish vaccine to combat canine leishmaniasis
  • 15.3.9. Merck Animal Health acquires Elanco's aqua business to strengthen aquaculture presence
  • 15.3.10. Huateng Pharma expands with fluralaner and sarolaner launch, revolutionizing veterinary pharmaceuticals
  • 15.3.11. ENTOD Pharmaceuticals expands into veterinary market with "FUR by ENTOD" division
  • 15.3.12. Indian Immunologicals Ltd (IIL) invests INR 700 crore in Hyderabad vaccine plant to boost livestock disease eradication
  • 15.3.13. Virbac acquires stake in Globion to boost avian vaccine market presence in India
  • 15.3.14. Strategic collaboration between Pirbright Institute and USask's VIDO to boost vaccine innovation and pandemic readiness
• 15.4. Strategy Analysis & Recommendation
  • 15.4.1. Dechra Pharmaceuticals PLC
  • 15.4.2. Zoetis Inc.
  • 15.4.3. Ceva Sante Animale
  • 15.4.4. Boehringer Ingelheim GmbH

Companies Mentioned

• 1. Aurora Pharmaceutical, Inc.
• 2. Biogenesis Bago S.A.
• 3. Biovac Ltd.
• 4. Boehringer Ingelheim International GmbH
• 5. Ceva Sante Animale
• 6. Chanelle Pharma
• 7. China Animal Husbandry Industry Co., Ltd.
• 8. Dechra Pharmaceuticals PLC
• 9. ECO Animal Health Group PLC
• 10. Elanco Animal Health Incorporated
• 11. Heska Corporation
• 12. Hester Biosciences Limited
• 13. Indian Immunologicals Ltd.
• 14. Intas Pharmaceuticals Ltd.
• 15. Laboratorio Drag Pharma Chile Invetec S.A.
• 16. Merck & Co., Inc.
• 17. Neogen Corporation
• 18. Norbrook Group
• 19. Phibro Animal Health Corporation
• 20. Teknofarma S.r.l.
• 21. Vetoquinol Group
• 22. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
• 23. Virbac S.A.
• 24. Zendal Group
• 25. Zoetis Inc.